Hangzhou AGS MedTech Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005ZF0
CNY
64.10
0.48 (0.75%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Net Sales
586.91
629.85
504.36
367.24
305.47
171.95
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
586.91
629.85
504.36
367.24
305.47
171.95
Raw Material Cost
181.61
182.45
150.93
121.03
110.88
70.11
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
166.97
182.02
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.43
0.37
0.25
0.23
0.14
0.09
Selling and Distribution Expenses
117.18
102.73
96.26
65.59
50.84
35.03
Other Expenses
-9.39
-12.40
4.03
3.04
2.34
1.79
Total Expenditure (Excl Depreciation)
372.32
343.61
287.79
217.27
185.28
123.14
Operating Profit (PBDIT) excl Other Income
214.60000000000002
286.2
216.6
150
120.19999999999999
48.8
Other Income
50.31
59.62
35.81
16.75
2.75
4.63
Operating Profit (PBDIT)
275.99
351.92
259.18
173.37
125.37
56.11
Interest
0.43
0.37
0.25
0.23
0.14
0.09
Exceptional Items
2.62
2.09
0.45
0.13
1.09
0.00
Gross Profit (PBDT)
405.30
447.41
353.43
246.22
194.59
101.85
Depreciation
16.14
10.05
7.71
7.70
6.36
4.98
Profit Before Tax
262.05
343.60
251.67
165.56
119.97
51.03
Tax
40.61
50.21
34.43
20.60
15.17
5.80
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
221.71
293.39
217.24
144.96
104.80
45.23
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
221.71
293.39
217.24
144.96
104.80
45.23
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.28
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
221.44
293.39
217.24
144.96
104.80
45.23
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,516.75
2,397.11
2,208.24
381.54
271.45
216.69
Earnings per share (EPS)
2.75
3.64
2.68
1.79
1.29
0.56
Diluted Earnings per share
2.75
3.64
2.68
1.79
1.29
0.56
Operating Profit Margin (Excl OI)
35.7%
44.81%
42.76%
40.55%
38.06%
27.04%
Gross Profit Margin
47.4%
56.15%
51.43%
47.18%
41.36%
32.58%
PAT Margin
37.78%
46.58%
43.07%
39.47%
34.31%
26.31%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is -6.83% vs 24.88% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is -24.54% vs 35.08% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is -22.78% vs 30.84% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 0.00% vs 33.33% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has fallen from Dec 2024

Compare Annual Results Of Hangzhou AGS MedTech Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
586.91
0
586.91
Other Operating Income
0.00
0.00
0.00
Total Operating income
586.91
0
586.91
Raw Material Cost
181.61
0
181.61
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
166.97
0
166.97
Power Cost
0
0
0.00
Manufacturing Expenses
0.43
0
0.43
Selling and Distribution Expenses
117.18
0
117.18
Other Expenses
-9.39
0.00
-9.39
Total Expenditure (Excl Depreciation)
372.32
0
372.32
Operating Profit (PBDIT) excl Other Income
214.59
0.00
214.59
Other Income
50.31
0
50.31
Operating Profit (PBDIT)
275.99
0
275.99
Interest
0.43
0
0.43
Exceptional Items
2.62
0
2.62
Gross Profit (PBDT)
405.30
0
405.30
Depreciation
16.14
0
16.14
Profit Before Tax
262.05
0
262.05
Tax
40.61
0
40.61
Provisions and contingencies
0
0
0.00
Profit After Tax
221.71
0
221.71
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
221.71
0
221.71
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.28
0
-0.28
Other related items
0.00
0.00
0.00
Consolidated Net Profit
221.44
0
221.44
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,516.75
0
2,516.75
Earnings per share (EPS)
2.75
0
2.75
Diluted Earnings per share
2.75
0
2.75
Operating Profit Margin (Excl OI)
35.70%
0%
0.00
35.70%
Gross Profit Margin
47.40%
0%
0.00
47.40%
PAT Margin
37.78%
0%
0.00
37.78%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 58.69 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -6.83% vs 24.88% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 22.14 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -24.54% vs 35.08% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 22.57 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -22.78% vs 30.84% in Dec 2024

Annual - Interest
Interest 0.04 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 0.00% vs 33.33% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 35.70%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has fallen from Dec 2024